2010 PRESS RELEASE ARCHIVE
December 6, 2010 - Aquisition of GTC Biotherapeutics, Inc. by LFB Technologies S.A.S. Completed
November 12, 2010 - 13E-3
November 8, 2010 - 8-K
November 8, 2010 - GTC Biotherapeutics, Inc. Agrees to be Taken Private for $.30 Per Share
October 27, 2010 - GTC Biotherapeutics Reports Third Quarter 2010 Financial Results
October 20, 2010 - GTC Biotherapeutics to Host Third Quarter 2010 Earnings Call and Webcast on Wednesday, October 27th, 2010
October 19, 2010 - LFB Biotechnologies, S.A.S Offers to Take GTC Biotherapeutics, Inc. Private for $.28 Per Share
July 27, 2010 - GTC Biotherapeutics Reports Second Quarter 2010 Financial Results
July 20, 2010 - GTC Biotherapeutics to Host Second Quarter 2010 Earnings Call and Webcast on Tuesday, July 27, 2010
July 16, 2010 - GTC Biotherapeutics Regains US Rights to ATryn ; the First Recombinant Antithrombin Product Approved in the World
June 16, 2010 - GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
May 12, 2010 - GTC Biotherapeutics Reports First Quarter 2010 Financial Results
April 13, 2010 - GTC Enters Atryn Registration License with Bio Sidus Argentina
March 12, 2010 - GTC Biotherapeutics Reports Fourth Quarter and Fiscal Year End 2009 Financial Results
March 10, 2010 - GTC Biotherapeutics to Webcast Corporate Presentation at the ROTH 22nd Annual OC Growth Stock Conference
March 5, 2010 - GTC Biotherapeutics to Host Fourth Quarter and Year End 2009 Earnings Call and Webcast on Friday, March 12, 2010
March 1, 2010 - GTC Provides Update on TG20 Monoclonal Antibody Targeting CD20
February 22, 2010 - GTC Enters into Agreement to Receive $7 Million in Financing from LFB
February 3, 2010 - GTC Biotherapeutics to Webcast Corporate Presentation at the 12th Annual BIO CEO & Investor Conference
January 28, 2010 - GTC Provides Recombinant FVIIa Regulatory Update
January 8, 2010 - GTC Announces Conversion of LFBS Preferred Stock into Common Shares and Provides a Portfolio Update